Seeking Alpha

Tekmira announces leadership changes

  • Tekmira Pharmaceuticals (TKMR) announces some leadership changes.
  • Dr. Michael Abrams will become Executive VP and Chief Discovery Officer (he will resign as independent director).
  • A new unit focused on "medical countermeasures" will be led by Dr. Ian MacLachlan, who will also become Executive VP and Chief Technical Officer. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: